Editorials: Are HMG‐CoA Reductase Inhibitors Underutilized in Dialysis Patients?-Reference-Cited by-同舟云学术

Editorials: Are HMG‐CoA Reductase Inhibitors Underutilized in Dialysis Patients?

Published:2003-05 Issue:3 Volume:16 Page:179-185
ISSN:0894-0959
Container-title:Seminars in Dialysis
language:en
Short-container-title:Seminars in Dialysis

Author:

Seliger Stephen L.¹,Stehman‐Breen Catherine O.²

Affiliation:

1. Department of Medicine, Division of Nephrology, University of Washington, Seattle, Washington, and

2. Division of Nephrology, VA Puget Sound Health Care System, Seattle, Washington

Publisher

Wiley

Subject

Nephrology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1525-139X.2003.16036.x

Reference81 articles.

1. Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start?

2. National Kidney Foundation:Managing dyslipidemias in kidney failure: Kidney Disease Outcomes Quality Initiative. Available athttp://www.kidney.org/professionals/doqi/lipids.cfm accessedOctober 9 2002

3. Cholesterol in the Prediction of Atherosclerotic Disease

4. Lipoproteins, cardiovascular disease, and death. The Framingham study

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis of statin therapy in maintenance dialysis patients;Renal Failure;2015-07-03

2. Atorvastatin Reduces High Glucose Toxicity in Rat Peritoneal Mesothelial Cells;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2011-05

3. Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients;International Urology and Nephrology;2010-10-20

4. Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering;International Urology and Nephrology;2007-12-08

5. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: The Cholesterol Paradox Is Flawed; Cholesterol Must Be Lowered in Dialysis Patients;Seminars in Dialysis;2007-10-10